Food Allergy Therapeutics - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510244587

Publication Date:

October 29, 2024

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

An allergic response to peanuts usually occurs within minutes after exposure. Peanut allergy signs and symptoms can include skin reactions, such as hives, redness or swelling. Itching or tingling in or around the mouth and throat. Digestive problems, such as diarrhea, stomach cramps, nausea or vomiting.
The global market for Food Allergy Therapeutics was estimated to be worth US$ 7154 million in 2023 and is forecast to a readjusted size of US$ 12330 million by 2030 with a CAGR of 8.1% during the forecast period 2024-2030
The Allergy Therapeutics market is being driven by the increasing prevalence of allergies, including respiratory allergies, food allergies, and allergic skin conditions. The growing recognition of the impact of allergies on individuals' quality of life has spurred the demand for effective therapeutic solutions. Additionally, advancements in medical research and technology have led to the development of targeted and personalized allergy treatments, enhancing the market's growth. However, challenges in the Allergy Therapeutics market include the complexity of allergic reactions, which can vary widely among individuals, and the need for rigorous clinical trials to ensure the safety and efficacy of new treatments. Regulatory hurdles and the cost of developing novel therapies can also pose challenges for market growth. Overall, the market's evolution is marked by a focus on precision medicine and the pursuit of innovative treatments that provide long-lasting relief for allergy sufferers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Food Allergy Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Food Allergy Therapeutics by region & country, by Type, and by Application.
The Food Allergy Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Food Allergy Therapeutics.
麻豆原创 Segmentation
By Company
Viatris
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Segment by Type:
Epinephrine Injection
Antihistamines
Other
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Food Allergy Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Food Allergy Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Food Allergy Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Food Allergy Therapeutics Product Introduction
1.2 Global Food Allergy Therapeutics 麻豆原创 Size Forecast
1.3 Food Allergy Therapeutics 麻豆原创 Trends & Drivers
1.3.1 Food Allergy Therapeutics Industry Trends
1.3.2 Food Allergy Therapeutics 麻豆原创 Drivers & Opportunity
1.3.3 Food Allergy Therapeutics 麻豆原创 Challenges
1.3.4 Food Allergy Therapeutics 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Food Allergy Therapeutics Players Revenue Ranking (2023)
2.2 Global Food Allergy Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Food Allergy Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Food Allergy Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Food Allergy Therapeutics
2.6 Food Allergy Therapeutics 麻豆原创 Competitive Analysis
2.6.1 Food Allergy Therapeutics 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Food Allergy Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Food Allergy Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Epinephrine Injection
3.1.2 Antihistamines
3.1.3 Other
3.2 Global Food Allergy Therapeutics Sales Value by Type
3.2.1 Global Food Allergy Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Food Allergy Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Food Allergy Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Other
4.2 Global Food Allergy Therapeutics Sales Value by Application
4.2.1 Global Food Allergy Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Food Allergy Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Food Allergy Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Food Allergy Therapeutics Sales Value by Region
5.1.1 Global Food Allergy Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Food Allergy Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Food Allergy Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Food Allergy Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Food Allergy Therapeutics Sales Value, 2019-2030
5.2.2 North America Food Allergy Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Food Allergy Therapeutics Sales Value, 2019-2030
5.3.2 Europe Food Allergy Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Food Allergy Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Food Allergy Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Food Allergy Therapeutics Sales Value, 2019-2030
5.5.2 South America Food Allergy Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Food Allergy Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Food Allergy Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Food Allergy Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Food Allergy Therapeutics Sales Value
6.3 United States
6.3.1 United States Food Allergy Therapeutics Sales Value, 2019-2030
6.3.2 United States Food Allergy Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Food Allergy Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Food Allergy Therapeutics Sales Value, 2019-2030
6.4.2 Europe Food Allergy Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Food Allergy Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Food Allergy Therapeutics Sales Value, 2019-2030
6.5.2 China Food Allergy Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Food Allergy Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Food Allergy Therapeutics Sales Value, 2019-2030
6.6.2 Japan Food Allergy Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Food Allergy Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Food Allergy Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Food Allergy Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Food Allergy Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Food Allergy Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Food Allergy Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Food Allergy Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Food Allergy Therapeutics Sales Value, 2019-2030
6.9.2 India Food Allergy Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Food Allergy Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Viatris
7.1.1 Viatris Profile
7.1.2 Viatris Main Business
7.1.3 Viatris Food Allergy Therapeutics Products, Services and Solutions
7.1.4 Viatris Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Viatris Recent Developments
7.2 Bayer
7.2.1 Bayer Profile
7.2.2 Bayer Main Business
7.2.3 Bayer Food Allergy Therapeutics Products, Services and Solutions
7.2.4 Bayer Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Bayer Recent Developments
7.3 UCB Pharma
7.3.1 UCB Pharma Profile
7.3.2 UCB Pharma Main Business
7.3.3 UCB Pharma Food Allergy Therapeutics Products, Services and Solutions
7.3.4 UCB Pharma Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 J & J Recent Developments
7.4 J & J
7.4.1 J & J Profile
7.4.2 J & J Main Business
7.4.3 J & J Food Allergy Therapeutics Products, Services and Solutions
7.4.4 J & J Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 J & J Recent Developments
7.5 Perrigo
7.5.1 Perrigo Profile
7.5.2 Perrigo Main Business
7.5.3 Perrigo Food Allergy Therapeutics Products, Services and Solutions
7.5.4 Perrigo Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Perrigo Recent Developments
7.6 GSK
7.6.1 GSK Profile
7.6.2 GSK Main Business
7.6.3 GSK Food Allergy Therapeutics Products, Services and Solutions
7.6.4 GSK Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 GSK Recent Developments
7.7 Kaleo
7.7.1 Kaleo Profile
7.7.2 Kaleo Main Business
7.7.3 Kaleo Food Allergy Therapeutics Products, Services and Solutions
7.7.4 Kaleo Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Kaleo Recent Developments
7.8 Amneal Pharma
7.8.1 Amneal Pharma Profile
7.8.2 Amneal Pharma Main Business
7.8.3 Amneal Pharma Food Allergy Therapeutics Products, Services and Solutions
7.8.4 Amneal Pharma Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 Amneal Pharma Recent Developments
7.9 ALK Abello
7.9.1 ALK Abello Profile
7.9.2 ALK Abello Main Business
7.9.3 ALK Abello Food Allergy Therapeutics Products, Services and Solutions
7.9.4 ALK Abello Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 ALK Abello Recent Developments
7.10 Aimmune Therapeutics
7.10.1 Aimmune Therapeutics Profile
7.10.2 Aimmune Therapeutics Main Business
7.10.3 Aimmune Therapeutics Food Allergy Therapeutics Products, Services and Solutions
7.10.4 Aimmune Therapeutics Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Aimmune Therapeutics Recent Developments
7.11 HUAPONT Pharm
7.11.1 HUAPONT Pharm Profile
7.11.2 HUAPONT Pharm Main Business
7.11.3 HUAPONT Pharm Food Allergy Therapeutics Products, Services and Solutions
7.11.4 HUAPONT Pharm Food Allergy Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 HUAPONT Pharm Recent Developments
8 Industry Chain Analysis
8.1 Food Allergy Therapeutics Industrial Chain
8.2 Food Allergy Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Food Allergy Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Food Allergy Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Viatris
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.